In this session from the 6th Annual CAR-TCR Summit, Faruk Abdullah, Head of U.S. Consulting, EVERSANA™ MANAGEMENT CONSULTING and Maria Kirsch, SVP & Head of Patient Services share insight on building the future commercialization model designed specifically for CAR-T, including:
- Key differences between CAR-T and traditional therapies
- Ideas, tactics and techniques needed to address CAR-T’s unique challenges
- Navigating the healthcare ecosystem beyond oncology that requires a deep level of interaction and coordination with supply chain, hospital operations, nurses and other key stakeholders
- The need to not only showcase the product value proposition, but also train on the therapy’s MOA, administration and usage
Author
Maria Kirsch is a decisive, strategic and forward-thinking leader with more than 20 years of experience across operational excellence and strategic development in the pharmaceutical industry. She previously served as Head of Patient Experience,…
Faruk is a life sciences professional with extensive experience addressing a broad range of strategic issues, including corporate development, portfolio planning, and launch excellence.